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Seroprevalences to viral pathogens in free-ranging and captive
cheetahs (Acinonyx jubatus) on Namibian farmland
Abstract
Cheetah populations are diminishing rapidly in their natural habitat. One reason for their decline is
thought to be a high susceptibility to (infectious) diseases because cheetahs in zoos suffer from high
disease-induced mortality. Data on the health status of free-ranging cheetahs are scarce and little is
known about their exposure and susceptibility to infectious diseases. We determined seroprevalence to
nine key viruses (feline herpesvirus 1, feline calicivirus, feline parvovirus, feline corona virus, canine
distemper virus, feline immunodeficiency virus, puma lentivirus, feline leukemia virus and rabies virus)
in 68 free-ranging cheetahs on east-central Namibian farmland, 24 non-vaccinated Namibian captive
cheetahs and several other wild carnivore species, and conducted necropsies of cheetahs and other wild
carnivores. Eight of eleven other wild carnivores were sero-positive for at least one of the viruses,
including the first record of an FIV-like infection in a wild felid west of the Kalahari, the caracal (Felis
caracal). Seroprevalences of the free-ranging cheetahs were below 5% for all nine viruses, significantly
lower than seroprevalences in non-vaccinated captive cheetahs and for five of seven viruses in
free-ranging cheetahs from north-central Namibia previously studied (1). There was no clinical or
pathological evidence for infectious diseases in living or dead cheetahs. The results suggest that - whilst
free-ranging wild carnivores may be a source of pathogens -, the distribution of seroprevalences across
studies mirrored local human population density and factors associated with human habitation, probably
reflecting contact opportunities with (non-vaccinated) domestic and feral cats and dogs. They also
suggest that Namibian cheetahs respond effectively to viral challenges, encouraging consistent and
sustainable conservation efforts. 1. Munson, L., L. Marker, E. Dubovi, J. A. Spencer, J. F. Evermann,
and S. J. O'Brien. 2004. J. Wildl. Dis. 40:23-31.
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Cheetah populations are diminishing rapidly in their natural habitat. One reason for their decline is thought
to be a high susceptibility to (infectious) diseases because cheetahs in zoos suffer from high disease-induced
mortality. Data on the health status of free-ranging cheetahs are scarce, and little is known about their
exposure and susceptibility to infectious diseases. We determined seroprevalences to nine key viruses (feline
herpesvirus 1, feline calicivirus, feline parvovirus, feline coronavirus, canine distemper virus, feline immuno-
deficiency virus [FIV], puma lentivirus, feline leukemia virus, and rabies virus) in 68 free-ranging cheetahs on
east-central Namibian farmland, 24 nonvaccinated Namibian captive cheetahs, and several other wild carni-
vore species and conducted necropsies of cheetahs and other wild carnivores. Eight of 11 other wild carnivores
were seropositive for at least one of the viruses, including the first record of an FIV-like infection in a wild felid
west of the Kalahari, the caracal (Felis caracal). Seroprevalences of the free-ranging cheetahs were below 5%
for all nine viruses, which is significantly lower than seroprevalences in nonvaccinated captive cheetahs and
those for five of seven viruses in previously studied free-ranging cheetahs from north-central Namibia (L.
Munson, L. Marker, E. Dubovi, J. A. Spencer, J. F. Evermann, and S. J. O’Brien, J. Wildl. Dis. 40:23–31, 2004).
There was no clinical or pathological evidence of infectious diseases in living or dead cheetahs. The results
suggest that while free-ranging wild carnivores may be a source of pathogens, the distribution of seropreva-
lences across studies mirrored local human population density and factors associated with human habitation,
probably reflecting contact opportunities with (nonvaccinated) domestic and feral cats and dogs. They also
suggest that Namibian cheetahs respond effectively to viral challenges, encouraging consistent and sustainable
conservation efforts.
Knowledge of the health status and disease susceptibility of
threatened and endangered species is fundamental for under-
standing the population dynamics of such species and for plan-
ning truly sustainable and successful conservation strategies.
The global cheetah (Acinonyx jubatus) population has dimin-
ished drastically during the last century (31), yet the health
status and disease susceptibility of cheetahs have been studied
predominantly in captive cheetahs. Cheetahs kept in various
breeding facilities and zoos can suffer from infectious and
chronic degenerative diseases, with subsequent mortality (4,
11, 12, 15, 22, 40, 42, 49). The high mortality from infectious
diseases in captive cheetahs was suggested to be a consequence
of a lack of genetic variability at the class I loci of the major
histocompatibility complex (MHC) in this species (44, 45, 67),
because the MHC class I genes encode peptides that mediate
the immune response to viral infections (3). These studies
imply that free-ranging cheetahs should also show a high level
of mortality from infectious diseases.
Today, the largest free-ranging cheetah population lives in
Namibia, with most of them roaming on commercial farmland,
not in protected areas (35). Little is known about the exposure
and susceptibility of this cheetah population to infectious dis-
eases (41). Lions (Panthera leo) and spotted hyenas (Crocuta
crocuta), the cheetah’s main competitors and predators (8) and
potential sources of viral infections, are absent on Namibian
farmland. Other carnivore species that do live on Namibian
farmland and could potentially transmit viral diseases to chee-
tahs include leopards (Panthera pardus) and smaller wild car-
nivores as well as domestic or feral cats and dogs. Not all domestic
cats and dogs on Namibian farms, and hardly any feral ones, are
vaccinated. Because both cats and dogs can carry viral pathogens
transferable to cheetahs (55), free-ranging cheetahs that come
into contact with nonvaccinated cats and dogs may become ex-
posed to viral pathogens. The risk of cheetahs becoming infected
with a virus is expected to be higher in areas with high human
density, since in these areas contact with nonvaccinated cats and
dogs is likely to be increased.
In this study, we determined seroprevalences in free-ranging
cheetahs and nonvaccinated cheetahs kept on private farms in
east-central Namibia for nine key viruses: feline herpesvirus 1
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(FHV1), feline calicivirus (FCV), feline parvovirus (FPV), fe-
line coronavirus (FCoV), canine distemper virus (CDV), feline
immunodeficiency virus (FIV), puma lentivirus (PLV), feline
leukemia virus (FeLV), and rabies virus. We also screened sera
of various carnivore species on Namibian farmland for anti-
bodies against the same nine viruses. To examine incidences
of infectious diseases in cheetahs and other carnivores, we
checked all animals for the presence of clinical symptoms re-
lated to viral infections and opportunistically conducted nec-
ropsies on carnivore carcasses.
Because in east-central Namibia there are fewer and smaller
human centers and a lower human density on farmland than in
north-central Namibia, which has several major human centers
and a higher human density on farmland (29), we compared
the seroprevalences from this study with those for free-ranging
cheetahs previously studied in north-central Namibia (41). If
cats and dogs play an important role in the transmission of
pathogens to cheetahs, then seroprevalences in free-ranging
east-central cheetahs (our study) should be significantly lower
than those in north-central cheetahs. For nonvaccinated cap-
tive cheetahs kept in the vicinity of farmhouses and lodges, we
also expected a higher seroprevalence than that for free-rang-
ing east-central cheetahs, because rates of contact with nonvac-
cinated cats and dogs are likely to be higher than those for
free-ranging cheetahs and because pathogens are likely to ac-
cumulate in the enclosure and facilitate the infection of captive
group members.
MATERIALS AND METHODS
Study animals and sample collection. Between June 2002 and October 2004,
62 cheetahs ranging freely on commercially used farmland in east-central Nami-
bia (21°45S to 22°45S and 16°30E to 18°30E) were trapped, immobilized,
examined, sampled, and released again. Study animals included 35 adult males
(17 solitary and 18 in groups of 2 [n  6] or 3 [n  2]), 8 adult females (3 solitary
and 5 accompanied by their cubs), 11 cubs, and 8 independent juveniles (1
solitary and 7 in groups, of 3 and 4). Juveniles were assessed to be between 1 and
2 years old. We additionally trapped, examined, and sampled four adult leopards,
three adult caracals (Felis caracal), and one adult black-backed jackal (Canis
mesomelas). The study area was located approximately 200 km south of the area
where most free-ranging cheetahs of a previous study in north-central Namibia
were investigated (41). We further examined and sampled 24 adult cheetahs that
were kept in large enclosures in their natural habitat on seven farms and lodges
in central, southern, and northern Namibia. Seven of these captive cheetahs in
three facilities were vaccinated against FHV, FCV, and FPV with a combined
vaccine (FHV and FCV live, attenuated viruses and FPV inactivated virus;
Pfizer, Sandton, Republic of South Africa) and against rabies virus (Merial South
Africa Ltd., Halfway House, Republic of South Africa). For these cheetahs, only
serology results for viruses that they were not vaccinated against were included
in the analyses. Four free-ranging and one nonvaccinated captive cheetah were
sampled and tested a second time, after periods of 1, 2, 2, 3, and 13 months, and
one free-ranging cheetah was tested a total of three times, the initial time and
after periods of 1.5 and 4.5 months.
Most free-ranging cheetahs (49/62 cheetahs), all captive cheetahs, and all
leopards were immobilized with Hellabrunn mixture (100 mg/ml ketamine [Ky-
ron Laboratories, Benrose, Republic of South Africa] and 125 mg/ml xylazine
[Bayer, Isando, Republic of South Africa]), with a dosage of 0.04 ml/kg of body
weight corresponding to 4.0 mg/kg ketamine and 5.0 mg/kg xylazine. For the
remaining cheetahs, a mixture of ketamine (4.5 mg/kg) and medetomidine (0.08
mg/kg; Novartis, Spartan, Republic of South Africa) was used. Caracals were
immobilized with 6.0 mg/kg ketamine plus 0.08 mg/kg medetomidine, and the
jackal was immobilized with 3.0 mg/kg ketamine plus 0.05 mg/kg medetomidine.
Anesthesia of animals immobilized with Hellabrunn mixture was reversed with
yohimbine (0.1 mg/kg; Kyron Laboratories, Benrose, Republic of South Africa),
whereas animals immobilized with ketamine and medetomidine were reversed
with atipamezole (0.25 mg/kg for cheetahs, leopards, and caracals and 0.2 mg/kg
for the jackal; Novartis, Spartan, Republic of South Africa). All drugs were
administered intramuscularly.
Anesthetized cheetahs were checked for symptoms that might be related to
viral infections, such as diarrhea, fever, ocular or nasal discharge, and cachexia.
Venous blood was collected into serum blood tubes (BD Vacutainer Systems,
Plymouth, United Kingdom). Blood samples were kept at 4°C during transport to
the field station and were centrifuged at 5,000 rpm for 15 min. Serum was stored
at 196°C in a liquid nitrogen container and then transported and stored at
80°C until serology was performed.
Necropsies were conducted on 1 captive and 15 free-ranging cheetahs, 8
free-ranging leopards, 2 black-backed jackals, 1 African wild cat (Felis libyca), 1
bat-eared fox (Otocyon megalotis), 1 honey badger (Mellivora capensis), and 1
aardwolf (Proteles cristatus). Eight of the free-ranging cheetahs were shot by
farmers as “problem animals,” two were shot as trophies, two were found dead
on the road, and three were found dead in the field after they had been dead for
a few days. The captive cheetah was thin, had not fed well, and died 2 days after
immobilization for purposes other than for this study. This animal and two of the
free-ranging cheetahs were study animals previously sampled serologically. All
eight leopards were shot as trophies; the other six carnivores were found dead on
the road. Postmortem blood of six cheetahs not previously sampled serologically
and of three leopards was gently aspirated into a 5-ml syringe after cutting of a
large blood vessel and then transferred to a serum tube and processed as de-
scribed above. Tissue samples from cheetahs (3 brains, 6 hearts, 5 lungs, 12
stomachs, 7 pancreases, 14 livers, 14 spleens, 4 lymph nodes, 13 kidneys, and 13
adrenal glands), leopards (3 hearts, 2 lungs, 8 stomachs, 5 pancreases, 7 livers, 8
spleens, 5 lymph nodes, 6 kidneys, and 7 adrenal glands), jackals (1 lung, 1
stomach, 2 livers, 1 lymph node, and 2 kidneys), the wild cat (heart, spleen,
kidney, and adrenal gland), and the bat-eared fox (heart, lung, liver, and spleen)
were stored and transported in 10% or 4% buffered formalin solution for his-
topathological examination. Brain or spinal cord samples of seven cheetahs,
three leopards, one black-backed jackal, one honey badger, and one aardwolf
were stored and transported either at 196°C or in phosphate-buffered 50%
glycerol solution until tested against rabies virus antigen.
Testing for antibodies against FHV, FCV, FPV, FCoV, and CDV. Immunoflu-
orescence assays (IFAs) were conducted as described previously (19, 26), using
the following as antigens: a Swiss isolate obtained from a cat suffering from
herpes keratitis (Zurich 5–04) for FHV, the F9 strain (Veterinaria AG, Zurich,
Switzerland) for FCV, the FPL/01 strain (Veterinaria AG, Zurich, Switzerland)
for FPV, a transmissible gastroenteritis virus, the Purdue strain (48), for FCoV,
and the Onderstepoort strain (Veterinaria AG, Zurich, Switzerland) for CDV.
The result was considered positive if specific fluorescence was detected in in-
fected cells (19, 26) and seen at a titer dilution of at least 1:20 (19). This dilution
allows for detection of antibodies specific for the antigens of interest (19) and
usually also for nonspecific reactions in vaccinated cats. Since serology tests were
conducted only for nonvaccinated cheetahs, a titer dilution of 1:20 allowed
specific detection of antibodies. All positive sera were titrated in twofold serial
dilutions until fluorescence was no longer detected.
Quality control. All antigens used for the IFA were tested by PCR or reverse
transcription-PCR (RT-PCR) for the absence of possible contaminating agents
following previously described protocols for FHV (63), FPV (51), FCoV (16),
FIV (25), FeLV (20), and CDV (38). For FCV, primer and probe sequences
were derived from those published previously (18) and kindly provided by C.
Helps: forward primer, 5-GTTGGATGAACTACCCGCCAATC-3; reverse
primer, 5-CATATGCGGCTCTGATGGCTTGAAACTG-3; and probe, 5-TC
GGTGTTTGATTTGGCCTG-3.
Testing for FeLV antigen and antibodies against FIV. Enzyme-linked immu-
nosorbent assays (ELISAs) were used to detect FeLV p27 antigen, the major
core protein of the virus, as described previously (27). Sera that produced an
optical density (OD) of 25% of a defined positive control were considered
positive (28). Because it was shown that the detection of antibodies against FIV
for free-ranging felids is likely to be more sensitive using PLV than FIV antigens
(23, 62), two ELISAs were conducted: one using a recombinant FIV-Z2 trans-
membrane glycoprotein developed in the laboratory as described previously (7)
and one using a synthetic peptide derived from the transmembrane glycoprotein
of PLV (23). Sera of an FIV-infected domestic cat and of a lion naturally infected
by a lentivirus were used as positive controls under previously described condi-
tions (61).
Testing for antibodies against rabies virus and rabies antigen. Sera were
tested for the presence of rabies-specific virus-neutralizing antibody by the rapid
fluorescent-focus inhibition test (RFFIT), using a standard challenge virus as
described previously (10). WHO reference serum was included to determine the
international units/milliliter (IU/ml), and titers of 0.5 IU/ml were considered
positive (66). Brain and spine samples were tested by RT-PCR for the presence
VOL. 17, 2010 VIRAL INFECTIONS IN FREE-RANGING AND CAPTIVE CHEETAHS 233
of viral antigen, using murine neuroblastoma cell cultures as described previously
(10). Samples were tested at the Federal Research Centre for Virus Diseases of
Animals, Tu¨bingen, Germany, and the National Rabies Reference Laboratory,
Wusterhausen, Germany.
Histopathological examination. Tissue samples stored in formalin solution
were paraffin embedded, sectioned at 4 m, and stained with hematoxylin and
eosin (H&E). Samples of heart, liver, and kidney were additionally stained with
van Gieson stain, and stomach samples were stained with Warthin Starry’s silver
stain to detect Helicobacter bacteria.
Data and statistical analysis. Differences in seroprevalences were tested for
significance with Fisher’s exact test, using SYSTAT 12.0. P values of 0.05 were
considered significant. Seroprevalence test protocols used in this study and in the
study conducted in north-central Namibia (41) differed for some viruses. The
validity of comparison is assessed in detail in Discussion.
RESULTS
Prevalence of antibodies in cheetahs. Seroprevalences of
free-ranging cheetahs varied between 0 and 4.9% for the tested
viral antibodies and FeLV antigens (Table 1). Seroprevalences
of captive, nonvaccinated cheetahs ranged between 0 and
38.5% (Table 1). Antibody prevalences were lower for free-
ranging than captive cheetahs for FPV (P 0.028; n 80), CDV
(P  0.020; n  89), and rabies virus (P  0.0058; n  55).
Free-ranging cheetahs in this study had lower seropreva-
lences than free-ranging cheetahs in north-central Namibia
(41) for FCV (P  0.0001; n  116), FPV (P  0.0001; n 
117), FCoV (P  0.0001; n  138), and CDV (P  0.0012; n 
137), and there was a trend toward lower seroprevalence for
FHV (P  0.059; n  141) (Table 1). All free-ranging cheetahs
in our study tested seronegative for FeLV (n  66) and FIV
(n  48), consistent with previous findings in north-central
Namibia (41) (Table 1).
Five of the 12 free-ranging cheetahs of this study that were
seropositive for FHV, FCV, FPV, FCoV, CDV, or rabies virus
were solitary, whereas seven were part of a group. The seven
cheetahs that were part of a group were members from six
different groups. Only in one group did more than one member
(a lactating mother and one of her two cubs) test seropositive
for the same virus (FCV). Within nonvaccinated captive chee-
tahs, four of six groups with seropositive members contained
more than one individual positive for a specific pathogen.
There was no difference in the probability of exposure for a
specific virus between group members of free-ranging and non-
vaccinated captive cheetahs if one member was infected with
this virus (P  0.24; n  12).
One free-ranging cheetah and one nonvaccinated captive
cheetah were seropositive for more than one virus. The free-
ranging cheetah (the lactating female mentioned above) was
seropositive for FCV (titer, 1:40) and CDV (titer, 1:80), and
the captive cheetah was seropositive for FHV, FPV, FCoV,
and CDV (all titers were 1:160).
Four of the six cheetahs that were sampled repeatedly were
seronegative for all five viruses tested at all time periods. One
free-ranging cheetah was seronegative in the first tests but
seropositive for FHV (titer, 1:20) 1 month later. The other
free-ranging cheetah tested positive for FCoV (titer, 1:80)
when first examined but was negative for this virus 2 months
later. The same animal tested seronegative for CDV when first
examined but was seropositive (titer, 1:20) 2 months later, at
the second examination.
Two free-ranging and five nonvaccinated captive cheetahs
showed neutralizing activity against rabies virus in RFFIT, with
titers of 0.5 IU/ml and 4.2 IU/ml (Table 1). One of the sero-
positive free-ranging males (titer, 0.5 IU/ml) died 10 months
after sampling, when he and the two other males of his group
(both with titers of 0.5 IU/ml) were shot by a farmer. The
other seropositive free-ranging male (titer, 0.5 IU/ml) lived for
7 months after sampling before his carcass was found in the
field. Three of the five seropositive captive cheetahs were ob-
served after sampling. Two (both with a titer of 0.5 IU/ml)
lived until the end of the study period (28 months after sam-
pling), and one (titer, 4.2 IU/ml) died 22 months after sam-
pling. The latter was the cheetah that died 2 days following
immobilization. No information on the fate of the remaining
two cheetahs was available after sampling.
TABLE 1. Prevalence of antibodies and titer levels against eight viruses and presence of FeLV antigens in free-ranging and nonvaccinated
captive cheetahs in Namibia
Virus
Free-ranging, east-central Namibian
cheetahs Captive, nonvaccinated cheetahs
Pe
Prevalence (no.
of positive
cheetahs/total
no. of cheetahs
%) in free-
ranging, north-
central Namibian
cheetahsc
P
Prevalence (no. of
positive cheetahs/total
no. of cheetahs %)
Positive resultsa
Prevalence (no. of
positive cheetahs/total
no. of cheetahs %)
Positive result(s)a
FHV 2/67 (3.0) 1:20, 1:40 1/13 (7.7) 1:160 NS 9/74 (12.2) 0.059
FCV 3/67 (4.5) 2 	 1:20, 1:40 0/13 (0.0) NS 32/49 (65.3) 0.0001d
FPV 2/67 (3.0) 2 	 1:20 3/13 (23.1) 1:20, 1:40, 1:160 0.028b 24/50 (48.0) 0.0001d
FCoV 2/66 (3.0) 1:20, 1:80 1/22 (4.5) 1:160 NS 21/72 (29.2) 0.0001d
CDV 3/67 (4.5) 1:20, 1:40, 1:80 5/22 (22.7) 2 	 1:20, 1:40, 2 	 1:160 0.020b 17/70 (24.3) 0.0012d
FeLV 0/66 (0.0) 0/22 (0.0) 0/69 (0.0)
FIV 0/48 (0.0) 0/19 (0.0) 0/39 (0.0)
PLV 0/63 (0.0) 0/22 (0.0) Not tested
Rabies virus 2/42 (4.9) 2 	 0.5 5/13 (38.5) 3 	 0.5, 2 	 4.2 0.0058b Not tested
a Positive results are expressed as dilution titer levels for FHV, FCV, FPV, FCoV, and CDV and as IU/ml for rabies virus.
b Seroprevalence was higher in captive Namibian cheetahs than in free-ranging east-central Namibian cheetahs.
c Data are from reference 36.
d Seroprevalence was higher in free-ranging north-central cheetahs than in free-ranging east-central Namibian cheetahs.
e NS, not significant.
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Serology in free-ranging carnivores other than cheetahs.
Leopards were seropositive for CDV only, whereas caracals
were seropositive for FHV, FCV, FPV, FCoV, CDV, and/or
PLV, but not FIV (Table 2). One of the three caracals was
positive for six viruses, and all three caracals were positive for
FCoV (Table 2). The black-backed jackal was tested for FHV,
FCV, FPV, FCoV, CDV, FeLV, and PLV and was seropositive
only for FCoV (titer, 1:20).
Symptoms of viral infections. None of the 62 free-ranging
and 24 captive cheetahs, 4 leopards, 3 caracals, and 1 black-
backed jackal showed typical signs of an infectious viral dis-
ease, such as fever, anorexia, or ocular or nasal discharge.
Necropsies. None of the tissue samples obtained from chee-
tahs, leopards, jackals, the wild cat, and the bat-eared fox
during necropsies showed lesions related to viruses for which
serological analyses were conducted. Serum samples from six
cheetahs and three leopards were analyzed, and antibodies
against FCV were detected in one cheetah (titer, 1:20; result
included in Table 1), with antibodies against CDV detected in
two leopards (titers, 1:20 and 1:640; results included in Table
2). Some minor lesions were nevertheless observed: changes in
5 of 14 examined cheetah livers consisted of Ito-cell activation
(n  3), minimal centrilobular perivenular fibrosis (n  1), and
a focal minimal granulomatous lesion (n  1). The splenic
corpuscles were slightly activated in the spleens of 10 of 14
examined cheetahs, all 8 leopards, the wild cat, and the bat-
eared fox. In cheetahs and the wild cat, the corpuscle germinal
center diameters did not exceed the width of the corona,
whereas in leopards and the bat-eared fox, the germinal cen-
ters stood out and their diameters exceeded the width of the
corona. Furthermore, in the adrenal glands of 9 of 13 exam-
ined cheetahs, the cortical cells in the zona glomerulosa and/or
zona fascicularis were vacuolated, whereas no such vacuoliza-
tion was found in seven leopard samples. Five of 12 cheetah
stomach samples showed mild lymphoplasmatic infiltration in
the basal mucosa, with one sample (from the captive animal
that died 2 days after immobilization) being associated with the
presence of Helicobacter. Similar mild lymphoplasmatic infil-
trations in the basal stomach mucosa were found in three of
eight examined leopard samples.
All 13 brain and spinal cord samples from the cheetahs,
leopards, jackal, honey badger, and aardwolf tested negative
for rabies virus antigen, including the brain sample of a free-
ranging cheetah male who tested positive for rabies virus an-
tibodies and was found dead 7 months later.
DISCUSSION
Seroprevalence and sources of transmission. The preva-
lence of antibodies against FHV, FCV, FPV, FCoV, CDV,
FIV, and PLV and the occurrence of rabies virus and FeLV
antigens in free-ranging cheetahs were generally low, with the
highest prevalence being 4.9%, for rabies virus. In only one of
seven free-ranging cheetah groups was more than one individ-
ual seropositive for a specific virus. Since this was a lactating
mother and one of her cubs, it is likely that the antibodies were
transferred from the mother to the cub via maternal milk and
were not the consequence of an infection with the virus. Thus,
intraspecific contacts or encounters might not be sufficiently
frequent or intense to facilitate viral transmission and to main-
tain infections at a high level within groups or in the popula-
tion.
As expected, seroprevalence among cheetahs living in areas
with a lower density of people (0.1 to 1.0 person/km2 [39]), and
therefore a lower density of domestic and feral cats and dogs,
was lower than that among cheetahs living in an area with a
higher density of people (1 to 5 people/km2 [39]) and therefore
a higher density of nonvaccinated domestic and feral animals.
It is unlikely that the difference in seroprevalence between the
cheetahs of the two areas was due to differences in intraspecific
contact rates, because cheetah densities are similar in the two
areas (17). Differences in interspecific contact rates with other
wild carnivores are possible, but the densities of leopards are
similar in the two areas (17), and densities of other carnivores
are also likely to be similar. FPV, FCoV, and CDV—for which
some of the seven leopards, three caracals, and one jackal
tested positive—can also be transmitted through contact with
infected feces; thus, other carnivores may be potential infec-
tion sources for cheetahs via fecal-oral transmission (9, 37, 65).
Are differences in seroprevalence between the cheetahs in
the two areas likely to be a consequence of differences in test
protocols, cutoff levels to determine positive results, or antigen
strains in the two studies? The previous study investigating
cheetahs in the area of higher human density (41) applied IFA
TABLE 2. Prevalence of antibodies and titer levels against eight viruses and presence of FeLV antigens among free-ranging
leopards and caracals
Virus
Leopards Caracals
Prevalence (no. of positive
leopards/total no. of
leopards %)
Positive resultsa
Prevalence (no. of positive
caracals/total no. of
caracals %)
Positive resultsa
FHV 0/7 (0.0) 2/3 (66.7) 1:20, 1:40
FCV 0/7 (0.0) 2/3 (66.7) 2 	 1:20
FPV 0/7 (0.0) 2/3 (66.7) 1:20, 1:1,280
FCoV 0/7 (0.0) 3/3 (100.0) 1:320, 1:640, 1:1,280
CDV 4/7 (57.1) 1:20, 1:80, 1:160, 1:640 2/3 (66.7) 2 	 1:320
FeLV 0/6 (0.0) 0/2 (0.0)
FIV 0/3 (0.0) 0/3 (0.0)
PLV 0/6 (0.0) 3/3 (100.0) 43, 96, 105
Rabies virus 0/2 (0.0) Not tested
a Positive results are expressed as dilution titer levels for FHV, FCV, FPV, FCoV, and CDV and as optical densities (%) for PLV.
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and serum neutralization tests (1992–1993 and 1993–1998, re-
spectively) to detect FHV and FCV antibodies (this study used
IFA), IFA and hemagglutination inhibition assays (1992–1993
and 1993–1998, respectively) to detect FPV antibodies (this
study used IFA), serum neutralization tests to detect CDV
antibodies (this study used IFA), and Western blotting to de-
tect FIV antibodies (this study used ELISA). Only FCoV an-
tibodies and FeLV antigens were tested with the same tests in
both studies (IFA and ELISA, respectively). Comparable cut-
off levels were specified only for FCoV (titer of 1:25 in refer-
ence 13 of reference 41), and antigen strains used for antibody
detection were mentioned for only two viruses. For CDV, the
previous study used the Onderstepoort strain, the same strain
used in this study, and for FIV, the Petaluma strain (46) was
used, which differs from the strain used in this study. However,
the use of different antigens and protocols is likely to lead to
different results only if the investigated virus is highly variable
in antigenicity (46, 62), as is likely the case with FCV and
FCoV (24, 50), but not if it is antigenically conserved, as is
likely with FHV, FPV, and CDV (14, 21, 36). Also, serum
neutralization tests are more specific than IFA because in the
former tests antibodies are detected only when they bind to
relatively small areas on the viral surface, which results in the
inhibition of infectivity (54). In contrast, IFA detects antibod-
ies directed to a broader array of epitopes on the viral surface.
We concluded that the higher seroprevalences in north-
central than east-central Namibian cheetahs for FHV, FCV, FPV,
and CDV are likely to reflect genuine differences in seropreva-
lence, because these viruses are conserved and/or their anti-
bodies in north-central Namibian cheetahs were tested with
the serum neutralization test. We therefore suggest that the
significant difference in seroprevalences between the two study
areas is a consequence of one or several biological causes that
effectively change transmission opportunities for pathogens.
We consider the likely difference in densities of nonvaccinated
domestic and feral cats and dogs to be one factor likely to
promote virus transmission to cheetahs. For CDV, the high
seroprevalence of 24% between 1992 and 1998 in north-central
Namibia (41) might also have been a consequence of a CDV
pandemic in sub-Saharan Africa in the mid-1990s (1, 41, 52).
Comparison of free-ranging and captive populations. Non-
vaccinated captive cheetahs on farms and lodges had higher
seroprevalences for FPV, CDV, and rabies virus than did free-
ranging cheetahs in east-central Namibia. This provides addi-
tional support that nonvaccinated domestic cats and dogs may
transfer viral antigens to cheetahs. In a reported case of a
captive cheetah that died of infection with FeLV, a domestic
cat was traced to have been the source of infection (32). In the
case of antibodies against CDV, transmission of human mor-
billivirus to captive cheetahs might also have been possible,
leading to transient infection without clinical signs and induc-
ing antibodies cross-reacting with CDV (58).
There was no difference in the probability of group members
among nonvaccinated captive and free-ranging cheetahs be-
coming infected with a specific virus if one member was in-
fected with this virus. Thus, pathogens do not appear to
accumulate and facilitate the infection of group members in
enclosures. Seropositive nonvaccinated captive cheetahs, like
free-ranging cheetahs, showed no evidence of disease suscep-
tibility in terms of external clinical signs, and the owners of the
farms where the captive cheetahs were housed did not report
any signs before or after blood sampling.
FIV and FIV-like exposure and infection. None of the car-
nivores tested with FIV-ELISA had antibodies against FIV.
This is consistent with results of previous studies in Namibia,
which also did not find seropositivity (5, 41, 46, 57). Since
free-ranging felids in other parts of southern Africa and east-
ern Africa were shown to be FIV positive (5, 46, 47, 57), it was
suggested that the Kalahari desert represents a faunal barrier
isolating the Namibian free-ranging felid populations from
populations further east (5).
Whereas cheetahs and leopards tested with PLV-ELISA in
this study were seronegative for PLV, the three tested caracals
were seropositive for PLV. This is the first report, to our
knowledge, of an FIV-like infection in a free-ranging felid in
Namibia and suggests that an FIV-like infection was present in
the area but was not detected with the FIV-ELISA protocol
developed for domestic cats. It has previously been shown that
the FIV transmembrane protein carries immunodominant
epitopes which do not cross-react with those of lentiviruses of
lions and pumas (6, 7). The results for caracals suggest that it
might be useful to apply PLV-ELISA to test nondomestic
felids and that actual infections in the wild may remain unde-
tected using the FIV-ELISA developed for domestic cats.
Since the immunodeficiency virus is transmitted primarily
through intense physical contact, such as biting, and since such
contact between caracals and cheetahs can be assumed to be
rare in the wild, it might be unlikely that this virus is transmit-
ted from caracals to cheetahs. Nevertheless, it is important to
continue testing free-ranging Namibian cheetahs with PLV-
ELISA, since currently this population appears to be free of
FIV and FIV-like infections and any change in seroprevalence
should be detected as early as possible.
Exposure to rabies virus. The low neutralizing activity
against rabies virus in the seven seropositive cheetahs, with
titers of 0.5 IU/ml (threshold of positivity) and 4.2 IU/ml, is
difficult to interpret, as the threshold for positivity is arbitrarily
defined and specific reactions cannot be distinguished from
unspecific reactions. The negative rabies virus antigen result
for the brain sample of one of these seropositive animals in-
dicates, however, that the viral load, if present, was low. All
rabies virus-positive cheetahs lived for many months after
blood sampling without expressing clinical signs of virulent
rabies virus infection. This contrasts with the common percep-
tion that rabies virus is an aggressive pathogen, usually leading
to death within a few days or weeks after incubation (53), but
is consistent with studies on spotted hyenas (Crocuta crocuta)
(10) and bats (Myotis myotis) (2). In spotted hyenas, 50% of 37
seropositive animals survived for more than 4.4 years after
blood sampling, and there was no association between longev-
ity and exposure to the virus (10). Similarly, in Myotis myotis
bats, all 37 seropositive animals that were recaptured survived
for at least 1 year and for up to 8 years, and mortality did not
increase after episodes of viral infection (2). Cheetahs in
Namibia might become infected with the virus through bites by
other carnivores. Consumption of rabies virus-infected prey
species might be another possibility for interspecific transmis-
sion of rabies to cheetahs, because rabies virus regularly causes
serious disease outbreaks among kudus in Namibia (30), and
kudus are a common prey of cheetahs (33, 64). Contact with a
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low viral load via mucous membranes may lead to abortive
infection and induction of the immune response.
Vulnerability to pathogens and stress. Recently, a new ex-
planation for increased susceptibility to infectious diseases in
cheetahs kept in zoos was suggested. Captive cheetahs in
North American zoos had higher fecal glucocorticoid concen-
trations and a larger adrenal corticomedullary ratio, indicative
of chronic stress, than those of free-ranging Namibian cheetahs
(59), suggesting that a hormone-based suppression of the im-
mune response may negatively affect health in captive cheetahs
(59). Free-ranging Namibian and captive North American
cheetahs investigated in previous studies originated from the
same gene pool (34), and thus the development of diseases in
cheetahs might be modulated by stress levels rather than ge-
netic predisposition (56). Since free-ranging and captive Nami-
bian cheetahs have similar fecal corticoids (59, 60) and similar
adrenal gland sizes, as measured by ultrasonography (61), glu-
cocorticoid influences on viral infections should be similar un-
der both study conditions, and these cheetahs should not be
highly susceptible to infectious diseases, as was found in this
study. These findings are in line with a previous study that
demonstrated that free-ranging cheetah females reproduce
well and that the low genetic variability of cheetahs is unlikely
to negatively affect the reproductive performance of cheetah
females (61).
If short-term stress increases the probability of disease out-
breaks in infected cheetahs, as was suggested for long-term
stress in zoos (59), translocation and similar potentially stress-
ful handling should be conducted with caution, as this may
compromise the successful immune response to viruses an in-
dividual may have been exposed to, especially in areas with
high levels of seroprevalence, where the chance of handling a
seropositive animal is high. Translocation of cheetahs is con-
ducted regularly in Namibia, by authorized organizations, when
farmers have trapped a cheetah and want to have it removed
from their farm to decrease the chance of livestock being killed
by it (35). Translocated cheetahs on Namibian farmland are
rarely monitored after release, and thus cheetahs that develop
virulent infection after translocation are unlikely to be re-
corded. It seems reasonable to suggest that translocation from
areas with high infection levels to areas with low infection
levels should be avoided to avoid the risk of exposure for
seronegative cheetahs. Also, translocation from areas with low
infection levels to areas with high infection levels should be
avoided because it might increase the risk of viral exposure for
seronegative, naïve cheetahs.
The minor lesions found in necropsied cheetah organs were
similar to previously described lesions (43). The observed dif-
ferences in the morphology of splenic corpuscles in cheetahs
and the wild cat and that in the bat-eared fox and leopards
could, however, not be interpreted. Nor is it currently known
whether the vacuolization of cheetah adrenal cortical cells that
was absent in leopard samples might reflect a functional dif-
ference. Future studies that also include hormonal measure-
ments for these species might shed light on these results.
Conclusions. This study suggests that free-ranging and cap-
tive Namibian cheetahs from the same population are in good
health, despite reports of low genetic variability (44, 45). This
result is encouraging for conservation plans concerning free-
ranging cheetahs and is useful for studies on cheetah popula-
tion dynamics.
ACKNOWLEDGMENTS
We thank the Ministry of Environment and Tourism in Namibia for
permission to conduct the study and the Seeis, Hochfeld, and Khomas
Conservancies and seven private facilities housing captive cheetahs for
cooperation. We highly appreciate the assistance and support of B.
Fo¨rster and H. Fo¨rster, whose preparatory work provided the basis for
the acceptance by and cooperation of the local farmers. We are grate-
ful to U. Tubessing, M. Jago, R. Hermes, F. Go¨ritz, and T. B. Hilde-
brandt for advice and help with anesthesia and investigating the ani-
mals, to M. Biering, U. Dreher, D. Krumnow, and B. Weibel for
assistance in the laboratory, to D. Thierer and K. Wilhelm for technical
support, and to M. L. East and O. P. Ho¨ner for improving the manu-
script. Part of the laboratory work was performed using the logistics of
the Centre for Clinical Studies at the Vetsuisse Faculty of the Univer-
sity of Zurich.
This study was financed by the Messerli Foundation, Switzerland,
the Leibniz Institute for Zoo and Wildlife Research, Germany, and the
United Bank of Switzerland (UBS) on behalf of an anonymous cus-
tomer.
REFERENCES
1. Alexander, K. A., P. W. Kat, L. A. Munson, A. Kalake, and M. J. G. Appel.
1996. Canine distemper-related mortality among wild dogs (Lycaon pictus) in
Chobe National Park, Botswana. J. Zoo Wildl. Med. 27:426–427.
2. Amengual, B., H. Bourhy, M. Lo´pez-Roig, and J. Serra-Cobo. 2007. Tem-
poral dynamics of European bat lyssavirus type I and survival of Myotis
myotis bats in natural colonies. PLoS One 2:e566.
3. Bjorkman, P. J., M. A. Saper, B. Samraoui, W. S. Bennett, J. L. Strominger,
and D. C. Wiley. 1987. The foreign antigen binding site and T cell recognition
regions of class I histocompatibility antigens. Nature 329:512–518.
4. Bolton, L. A., and L. Munson. 1999. Glomerulosclerosis in captive cheetahs
(Acinonyx jubatus). Vet. Pathol. 36:14–22.
5. Brown, E. W., S. Miththapala, and S. J. O’Brien. 1993. Prevalence of expo-
sure to feline immunodeficiency virus in exotic felid species. J. Zoo Wildl.
Med. 24:357–364.
6. Brown, E. W., N. Yuhki, C. Packer, and S. J. O’Brien. 1994. A lion lentivirus
related to feline immunodeficiency virus: epidemiologic and phylogenetic
aspects. J. Virol. 68:5953–5968.
7. Calzolari, M., E. Young, D. Cox, D. Davis, and H. Lutz. 1995. Serological
diagnosis of feline immunodeficiency virus infection using recombinant
transmembrane glycoprotein. Vet. Immunol. Immunopathol. 46:83–92.
8. Caro, T. 1994. Cheetahs of the Serengeti plains: group living in an asocial
species. The University of Chicago Press, Chicago, IL.
9. Decaro, N., C. Desario, M. Campolo, G. Elia, V. Martella, D. Ricci, E.
Lorusso, and C. Buonavoglia. 2005. Clinical and virological findings in pups
naturally infected by canine parvovirus type 2 Glu-426 mutant. J. Vet. Diagn.
Invest. 17:133–138.
10. East, M. L., H. Hofer, J. Cox, U. Wulle, H. Wiik, and C. Pitra. 2001. Regular
exposure to rabies virus and lack of symptomatic disease in Serengeti spotted
hyenas. Proc. Natl. Acad. Sci. USA 98:15026–15031.
11. Eaton, K. A., M. J. Radin, L. Kramer, R. Wack, R. Sherding, S. Krakowka,
J. G. Fox, and D. R. Morgan. 1993. Epizootic gastritis associated with gastric
spiral bacilli in cheetahs (Acinonyx jubatus). Vet. Pathol. 30:55–63.
12. Evermann, J. F. 1986. Feline coronavirus infection of cheetahs. Feline Pract.
16:21–30.
13. Evermann, J. F., J. L. Heeney, M. E. Roelke, A. J. McKeirnan, and S. J.
O’Brien. 1988. Biological and pathological consequences of feline infectious
peritonitis virus infection in the cheetah. Arch. Virol. 102:155–171.
14. Gamoh, K., M. Senda, Y. Inoue, and O. Itoh. 2005. Efficacy of an inactivated
feline panleucopenia virus vaccine against a canine parvovirus isolated from
a domestic cat. Vet. Rec. 157:285–287.
15. Gosselin, S. J., D. L. Loudy, M. J. Tarr, W. F. Balistreri, K. D. R. Setchell,
J. O. Johnston, L. W. Kramer, and B. L. Dresser. 1988. Veno-occlusive
disease of the liver in captive cheetah. Vet. Pathol. 25:48–57.
16. Gut, M., C. M. Leutenegger, J. B. Huder, N. C. Pedersen, and H. Lutz. 1999.
One-tube fluorogenic reverse transcription-polymerase chain reaction for
the quantitation of feline coronaviruses. J. Virol. Methods 77:37–46.
17. Hanssen, L., and P. Stander. 2004. Namibia large carnivore atlas. Predator
Conservation Trust, Windhoek, Namibia.
18. Helps, C., P. Lait, S. Tasker, and D. Harbour. 2002. Melting curve analysis
of feline calicivirus isolates detected by real-time reverse transcription PCR.
J. Virol. Methods 106:241–244.
19. Hofmann-Lehmann, R., D. Fehr, M. Grob, M. Elgizoli, C. Packer, J. S. Mar-
tenson, S. J. O’Brien, and H. Lutz. 1996. Prevalence of antibodies to feline
VOL. 17, 2010 VIRAL INFECTIONS IN FREE-RANGING AND CAPTIVE CHEETAHS 237
parvovirus, calicivirus, herpesvirus, coronavirus, and immunodeficiency virus
and of feline leukemia virus antigen and the interrelationship of these viral
infections in free-ranging lions in East Africa. Clin. Diagn. Lab. Immunol.
3:554–562.
20. Hofmann-Lehmann, R., J. B. Huder, S. Gruber, F. Boretti, B. Sigrist, and H.
Lutz. 2001. Feline leukaemia provirus load during the course of experimen-
tal infection and in naturally infected cats. J. Gen. Virol. 82:1589–1596.
21. Horimoto, T., J. A. Limcumpao, X. Xuan, M. Ono, K. Maeda, Y. Kawaguchi,
C. Kai, E. Takahashi, and T. Mikami. 1992. Heterogeneity of feline herpes-
virus type 1 strains. Arch. Virol. 126:283–292.
22. Junge, R. E., E. Miller, W. Boever, G. Scherba, and J. Sundberg. 1991.
Persistent cutaneous ulcers associated with feline herpesvirus type 1 infec-
tion in a cheetah. J. Am. Vet. Med. Assoc. 198:1057–1058.
23. Kania, S. A., M. A. Kennedy, and L. N. D. Potgieter. 1997. Serologic reac-
tivity using conserved envelope epitopes in feline lentivirus-infected felids. J.
Vet. Diagn. Invest. 9:125–129.
24. Kummrow, M., M. L. Meli, M. Haessig, E. Goenczi, A. Poland, N. C. Pe-
dersen, R. Hofmann-Lehmann, and H. Lutz. 2005. Feline coronavirus sero-
types 1 and 2: seroprevalence and association with disease in Switzerland.
Clin. Diagn. Lab. Immunol. 12:1209–1215.
25. Leutenegger, C. M., D. Klein, R. Hofmann-Lehmann, C. Mislin, U. Hummel, J.
Bo¨ni, F. Boretti, W. H. Guenzburg, and H. Lutz. 1999. Rapid feline immuno-
deficiency virus provirus quantitation by polymerase chain reaction using the
TaqMan fluorogenic real-time detection system. J. Virol. Methods 78:105–116.
26. Lutz, H., B. Hauser, and M. Horzinek. 1984. Die Diagnostik der felinen
infektio¨sen Peritonitis mittels Serologie. Prakt. Tierarzt. 5:406–407.
27. Lutz, H., N. C. Pedersen, R. Durbin, and G. H. Theilen. 1983. Monoclonal
antibodies to three epitopic regions of feline leukemia virus p27 and their use
in enzyme-linked-immunosorbent assay of p27. J. Immunol. Methods 56:
209–220.
28. Lutz, H., N. C. Pedersen, and G. H. Theilen. 1983. Course of feline leukemia
virus infection and its detection by enzyme-linked immunosorbent assay and
monoclonal antibodies. Am. J. Vet. Res. 44:2054–2059.
29. Malan, J. S. 1995. Peoples of Namibia. Department of Anthropology, Uni-
versity of the North, Rhino Publisher, Pretoria, South Africa.
30. Mansfield, K., L. McElhinney, O. Hu¨bschle, F. Mettler, C. T. Sabeta, L. H.
Nel, and A. R. Fooks. 2006. A molecular epidemiological study of rabies
epizootics in kudu (Tragelaphus strepsiceros) in Namibia. BMC Vet. Res. 2:2.
31. Marker, L. 1998. Current status of the cheetah, p. 1–17. In B. L. Penzhorn
(ed.), A symposium on cheetahs as game ranch animals. Wildlife Group of
the South African Veterinary Association, Onderstepoort, South Africa.
32. Marker, L., L. Munson, P. A. Basson, and S. Quackenbush. 2003. Multicen-
tric T-cell lymphoma associated with feline leukemia virus infection in a
captive Namibian cheetah (Acinonyx jubatus). J. Wildl. Dis. 39:690–695.
33. Marker, L. L., J. R. Muntifering, A. J. Dickman, M. G. L. Mills, and D. W.
Macdonald. 2003. Quantifying prey preferences of free-ranging Namibian
cheetahs. S. Afr. J. Wildl. Res. 33:43–53.
34. Marker-Kraus, L., and J. Grisham. 1993. Captive breeding of cheetahs in
North American zoos: 1987–1991. Zoo Biol. 12:5–18.
35. Marker-Kraus, L., D. Kraus, D. Barnett, and S. Hurlbut. 1996. Cheetah
survival on Namibian farmlands. Cheetah Conservation Fund, Windhoek,
Namibia.
36. Masuda, M., H. Sato, H. Kamata, T. Katsuo, A. Takenaka, R. Miura, M.
Yoneda, K. Tsukiyama-Kohara, K. Mizumoto, and C. Kai. 2006. Character-
ization of monoclonal antibodies directed against the canine distemper virus
nucleocapsid protein. Comp. Immunol. Microbiol. Infect. Dis. 29:157–165.
37. Meli, M., A. Kipar, C. Mu¨ller, K. Jenal, E. Go¨nczi, N. Borel, D. Gunn-Moore,
S. Chalmers, F. Lin, M. Reinacher, and H. Lutz. 2004. High viral loads
despite absence of clinical and pathological findings in cats experimentally
infected with feline coronavirus (FCoV) type I and in naturally FCoV-
infected cats. J. Feline Med. Surg. 6:69–81.
38. Meli, M. L., V. Cattori, F. Martinez, G. Lo´pez, A. Vargas, M. A. Simo´n, I.
Zorrilla, A. Munoz, F. Palomares, J. V. Lo´pez-Bao, J. Pastor, R. Tandon, B.
Willi, R. Hofmann-Lehmann, and H. Lutz. 2009. Feline leukemia virus and
other pathogens as important threats to the survival of the critically endan-
gered Iberian lynx (Lynx pardinus). PLoS One 4:e4744.
39. Mendelsohn, J., A. Jarvis, C. Roberts, and T. Robertson. 2002. Atlas of
Namibia—a portrait of the land and its people. David Philip Publisher, Cape
Town, South Africa.
40. Munson, L. 1993. Disease of captive cheetahs (Acinonyx jubatus): results of the
cheetah research council pathology survey, 1989–1992. Zoo Biol. 12:105–124.
41. Munson, L., L. Marker, E. Dubovi, J. A. Spencer, J. F. Everman, and S. J.
O’Brien. 2004. Serosurvey of viral infections in free-ranging Namibian chee-
tahs (Acinonyx jubatus). J. Wildl. Dis. 40:23–31.
42. Munson, L., J. W. Nesbit, D. G. A. Meltzer, L. P. Colly, L. Bolton, and N. P. J.
Kriek. 1999. Disease of captive cheetahs (Acinonyx jubatus jubatus) in South
Africa: a 20-year retrospective survey. J. Zoo Wildl. Med. 30:342–347.
43. Munson, L., K. A. Terio, M. B. Worley, M. Jago, A. Bagot-Smith, and L.
Marker. 2005. Extrinsic factors significantly affect patterns of disease in
free-ranging and captive cheetah (Acinonyx jubatus) populations. J. Wildl.
Dis. 41:542–548.
44. O’Brien, S. J., M. E. Roelke, L. Marker, A. Newman, C. A. Winkler, D.
Meltzer, L. Colly, J. F. Evermann, M. Bush, and D. E. Wildt. 1985. Genetic
basis for species vulnerability in the cheetah. Science 227:1428–1434.
45. O’Brien, S. J., D. E. Wildt, D. Goldman, C. R. Merril, and M. Bush. 1983.
The cheetah is depauperate in genetic variation. Science 221:459–462.
46. Olmsted, R. A., R. Langley, M. E. Roelke, R. M. Goeken, D. Adger-Johnson,
J. P. Goff, J. P. Albert, C. Packer, K. M. Laurenson, T. M. Caro, L. Scheep-
ers, D. E. Wildt, M. Bush, J. S. Martenson, and S. J. O’Brien. 1992. World-
wide prevalence of lentivirus infection in wild feline species: epidemiologic
and phylogenetic aspects. J. Virol. 66:6008–6018.
47. Osofsky, S. A., K. J. Hirsch, E. E. Zuckermann, and W. D. Hardy. 1996. Feline
lentivirus and feline oncovirus status of free-ranging lions (Panthera leo), leop-
ards (Panthera pardus), and cheetahs (Acinonyx jubatus) in Botswana: a regional
perspective. J. Zoo Wildl. Med. 27:453–467.
48. Osterhaus, A. D. M. E., M. C. Horzinek, and D. J. Reynolds. 1977. Seroepi-
demiology of feline infectious peritonitis virus infection using transmissible
gastroenteritis virus as antigen. Zentralbl. Veterinarmed. B 24:835–841.
49. Papendick, R. E., L. Munson, T. D. O’Brien, and K. H. Johnson. 1997.
Natural disease: systemic AA amyloidosis in captive cheetahs (Acinonyx
jubatus). Vet. Pathol. 34:549–556.
50. Radford, A. D., S. Dawson, R. Ryvar, K. Coyne, D. R. Johnson, M. B. Cox,
E. F. J. Acke, D. D. Addie, and R. M. Gaskell. 2003. High genetic diversity of
the immunodominant region of the feline calicivirus capsid gene in endem-
ically infected cat colonies. Virus Genes 27:145–155.
51. Ramsauer, S., G. Bay, M. Meli, R. Hofmann-Lehmann, and H. Lutz. 2007.
Seroprevalence of selected infectious agents in a free-ranging, low-density
lion population in the Central Kalahari Game Reserve in Botswana. Clin.
Vaccine Immunol. 16:808–810.
52. Roelke-Parker, M. E., L. Munson, C. Packer, R. Kock, S. Cleveland, M.
Carpenter, S. O’Brien, A. Posposchil, R. Hofmann-Lehmann, H. Lutz,
G. L. M. Mwamengele, M. N. Mgasa, G. A. Machange, B. A. Summers, and
M. J. G. Appel. 1996. A canine distemper virus epidemic in Serengeti lions
(Panthera leo). Nature 379:441–445.
53. Rolle, M., and A. Mayr. 1993. Medizinische Mikrobiologie, Infektions- und
Seuchenlehre, 5th ed. Enke Verlag, Stuttgart, Germany.
54. Ruckerbauer, G. M., A. Girard, G. L. Bannister, and P. Boulanger. 1971.
Studies on bovine virus diarrhea: serum neutralization, complement-fixation
and immunofluorescence. Can. J. Comp. Med. 35:230–238.
55. Schneider, H. P. 1991. Animal health and veterinary medicine in Namibia.
Agrivet, Windhoek, Namibia.
56. Spencer, J. A. 1993. Lymphocyte blast transformation responses and restric-
tion fragment length analysis in the cheetah. Onderstepoort J. Vet. Res.
60:211–217.
57. Spencer, J. A., A. A. van Dijk, M. C. Horzinek, H. F. Egberink, R. G. Bengis,
D. F. Keet, S. Morikawa, and D. H. L. Bishop. 1992. Incidence of feline immu-
nodeficiency virus reactive antibodies in free-ranging lions of the Kruger Na-
tional Park and the Etosha National Park in southern Africa detected by re-
combinant FIV p24 antigen. Onderstepoort J. Vet. Res. 59:315–322.
58. Stephenson, J. R., and V. ter Meulen. 1979. Antigenic relationships between
measles and canine distemper viruses: comparison of immune response in
animals and humans to individual virus-specific polypeptides. Proc. Natl.
Acad. Sci. USA 76:6601–6605.
59. Terio, K. A., L. Marker, and L. Munson. 2004. Evidence for chronic stress in
captive but not free-ranging cheetahs (Acinonyx jubatus) based on adrenal
morphology and function. J. Wildl. Dis. 40:259–266.
60. Terio, K. A., L. Marker, E. W. Overstrom, and J. L. Brown. 2003. Analysis
of ovarian and adrenal activity in Namibian cheetahs. S. Afr. J. Wildl. Res.
33:71–78.
61. Thalwitzer, S. 2007. Reproductive activity in cheetah females, cub survival
and health in male and female cheetahs on Namibian farmland. Freie Uni-
versita¨t Berlin, Berlin, Germany.
62. van Vuuren, M., E. Stylianides, S. A. Kania, E. E. Zuckermann, and W. D.
Hardy. 2003. Evaluation of an indirect enzyme-linked immunosorbent assay
for the detection of feline lentivirus-reactive antibodies in wild felids, em-
ploying a puma lentivirus-derived synthetic peptide antigen. Onderstepoort
J. Vet. Res. 70:1–6.
63. Vo¨gtlin, A., C. Fraefel, S. Albini, C. M. Leutenegger, E. Schraner, B. Spiess,
H. Lutz, and M. Ackermann. 2002. Quantification of feline herpesvirus 1
DNA in ocular fluid samples of clinically diseased cats by real-time TaqMan
PCR. J. Clin. Microbiol. 40:519–523.
64. Wachter, B., O. Jauernig, and U. Breitenmoser. 2006. Determination of prey
hair in faeces in free-ranging Namibian cheetahs with a simple method. Cat
News 44:8–9.
65. Williams, E. S., E. T. Thorne, M. J. G. Appel, and D. W. Belitsky. 1988.
Canine distemper in black-footed ferrets (Mustela nigripes) from Wyoming.
J. Wildl. Dis. 24:385–398.
66. World Health Organization. 1978. WHO/IABS developments in biological
standards, p. 268–270. In W. Hennessen and R. H. Regamey (ed.), Sympo-
sium in the standardization of rabies vaccines for human use produced in
tissue cultures (rabies III). WHO, Marburg, Gemany.
67. Yuhki, N., and S. J. O’Brien. 1990. DNA variation of the mammalian major
histocompatibility complex reflects genomic diversity and population history.
Proc. Natl. Acad. Sci. USA 87:836–840.
238 THALWITZER ET AL. CLIN. VACCINE IMMUNOL.
